Gildea, L.; Ayariga, J.; Abugri, J.; Villafane, R. Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant Staphylococcus aureus. Preprints2021, 2021110397. https://doi.org/10.20944/preprints202111.0397.v1
Gildea, L., Ayariga, J., Abugri, J., & Villafane, R. (2021). Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant <em>Staphylococcus aureus</em>. Preprints. https://doi.org/10.20944/preprints202111.0397.v1
Gildea, L., James Abugri and Robert Villafane. 2021 "Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant <em>Staphylococcus aureus</em>" Preprints. https://doi.org/10.20944/preprints202111.0397.v1
The emergence of multidrug-resistant bacterial strains, especially in the clinical setting, has renewed interest in alternative treatment methods. The utilization of prokaryotic viruses in phage therapy has demonstrated potential as a novel treatment method against multidrug-resistant bacterial infections. As the post-antibiotic era quickly approaches, the development and standardization of phage therapy is critically relevant to public health. This review serves to highlight the development of phage therapy against methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant bacterial strain responsible for severe clinical infections.
Medicine and Pharmacology, Complementary and Alternative Medicine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.